Publishing: Journals, books and databases
Close Icon
Scheduled maintenance upgrade on Thursday 18 February 2016 from 10am to 12noon (GMT)
During this time you may experience an intermittent reduction in performance, with the possibility of our publishing platform services being offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.
Urgent high quality communications from across the chemical sciences.
Impact Factor 6.834 100 Issues per Year Indexed in Medline

Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity

Corresponding authors
Institute of Cancer Therapeutics, University of Bradford, West Yorkshire BD7 1DP, UK
Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, London, UK
School of Pharmacy, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK
Chem. Commun., 2011,47, 12062-12064

DOI: 10.1039/C1CC15638A
Received 12 Sep 2011, Accepted 04 Oct 2011
First published online 14 Oct 2011
| | | | | | More
Please wait while Download options loads

Supplementary Info